Drug Release from Hydroxyapatite Implants with Different Microstructure and Phase Composition

Abstract:

The goal of our studies has been to determine under in vitro conditions the amount and rate of pentoxifylline release from the samples of modified hydroxyapatite [HAp-Ca10(PO4)6(OH)2] implants in the form of microporous blocks (heterogeneous system) as well as from hydroxyapatitegypsum pellets (homogeneous system). For the preparation of microporous hydroxapatite ceramics additives of calcium metaphosphate Ca(PO3)2 (5 and 10 wt. %) or hydrated magnesium orthophosphate Mg3(PO4)2·8H2O (10 wt. %) were used as modifiers. In the case of drug release from heterogeneous carriers, cylinders filled with 50 mg of PTX were used. In the homogeneous system the pellets made of HAp and CaSO4·1/2H2O powders with homogeneously incorporated of 50 mg PTX were applied. It has been shown that the process of drug release from multifunctional ceramic implants depends to a significant degree on the microstructure of the materials, and the type of carrier system (heterogeneous or homogeneous).

• Periodical: Advances in Science and Technology (Volume 49)
• Pages: 62-67
• DOI: https://doi.org/10.4028/www.scientific.net/AST.49.62
• Online since: October 2006
• Authors: Aneta Zima, B. Mycek, Anna Ślósarczyk, J. Szymura-Oleksiak, Zofia Paszkiewicz
• Keywords: Ceramic Carriers of Drugs, Hydroxyapatite Implant

References

[1] Orive G., i inni: Drug Delivery in Biotechnology: Present i Future, Current Opinion in Chemical Biology 14 (2003) 659-664.

DOI: 10.1016/j.copbio.2003.10.007

[2] Alekha K., Cudworth II D.: Therapeutic Aplication of Impalnatble Drug Delivery Systems, Journal of Pharmacological and Toxicological Methods 40 (1998) 1-12.

[3] Pillai O., Dhanikula A.B., Panchagnula R.: Drug Delivery: An Odyssey of 100 years, Current Opinion in Chemical Biology 5 (2001) 439-446.

DOI: 10.1016/s1367-5931(00)00226-x

[4] Torchilin V.P.: Drug Targeting, European Journal Of Pharmaceutica Science 11 (2000) 81-91.

[5] De Groot K.: Effect of porosity and physical-chemical properties on the stability, resorption and strenght of calcium phosphate ceramics, Biomaterials (1988).

[6] Razzacki S.: Integrated Microsystems for Controlled Drug Delivery, Advanced Drug Delivery Revievs 56 (2004) 185-198.

DOI: 10.1016/j.addr.2003.08.012

[7] Paradowski T., Zeman K.: Pentoksyfilina, Post. Hig. Med. Dośw. 49 (1995) 201-220.

[8] Otsuka M., Matsuda Y., Suwa Y., Fox J.L., Higuchi W.I.: A novel skeletal drug delivery system using self-setting calcium phosphate cement. 5. Drug release behavior from a heterogeneous drug-loaded cement containing an anticancer drug. J Pharm Sci 83 (11) (1994).

DOI: 10.1002/jps.2600831109

[9] Peppas N.A., Sahlin J.J.: A sample equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm. 57 (1989) 169-172.

DOI: 10.1016/0378-5173(89)90306-2

[10] Sood A., Panchagnula R.: Role of dissolution studies in controlled release drug delivery systems. S.T.P. Pharma Sciences 9 (2) (1999) 157-168.